NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?

Insider buying vs selling

Have Nautilus Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ah Equity Partners Bio II LLC10% Owner2026-06-024,615,974$2.35
$10.85MSell
Ah Equity Partners Bio II LLC10% Owner2026-06-02384,026$2.35
$902.46kSell
Sujal M. PatelCEO President and Secretary2026-03-0425,000$2.61
$65.25kBuy
Kentaro SuzukiChief Marketing Officer2025-11-064,000$1.49
$5.96kBuy

1 of 1

NAUT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAUT insiders and whales buy or sell their stock.

NAUT Shareholders

What type of owners hold Nautilus Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Parag Mallick16.10%20,493,392$19.92MInsider
Sujal M. Patel15.15%19,275,267$18.74MInsider
Vijay Satyanand Pande13.87%17,653,917$17.16MInsider
Ah Equity Partners Bio II LLC9.94%12,653,917$12.30MInsider
Perceptive Advisors LLC7.16%9,111,151$8.86MInsider
Matthew S. McIlwain5.09%6,479,845$6.30MInsider
Farzad Nazem1.48%1,888,146$1.84MInsider
Matthew L. Posard0.12%150,000$145.80kInsider
Subramanian Sankar0.07%91,250$88.70kInsider
Anna Mowry0.07%83,000$80.68kInsider

1 of 3

NAUT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAUT0.04%69.14%Net Selling
VTVT0.00%100.00%Net Buying
CBUS0.02%64.61%Net Buying
INO0.03%30.13%Net Selling
AARD0.04%46.39%Net SellingNet Selling

Nautilus Biotechnology Stock Ownership FAQ

Who owns Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ: NAUT) is owned by 0.04% institutional shareholders, 69.14% Nautilus Biotechnology insiders, and 30.82% retail investors. Parag Mallick is the largest individual Nautilus Biotechnology shareholder, owning 20.49M shares representing 16.10% of the company. Parag Mallick's Nautilus Biotechnology shares are currently valued at $19.92M.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.